Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
Top Cited Papers
- 1 January 2008
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 54 (1) , 141-150
- https://doi.org/10.1016/j.neuropharm.2007.07.005
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Endocannabinoids modulate stress‐induced suppression of hippocampal cell proliferation and activation of defensive behavioursEuropean Journal of Neuroscience, 2006
- Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404Neuropsychopharmacology, 2006
- Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brainNeuroscience, 2006
- Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysisProceedings of the National Academy of Sciences, 2005
- Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years onNeuroscience & Biobehavioral Reviews, 2005
- Context‐dependent effects of CB1 cannabinoid gene disruption on anxiety‐like and social behaviour in miceEuropean Journal of Neuroscience, 2004
- The mouse light/dark box testPublished by Elsevier ,2003
- Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinolPsychopharmacology, 2002
- Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseProceedings of the National Academy of Sciences, 2001
- Adverse effects of cannabisThe Lancet, 1998